VivoSim Labs, Inc.

US$0.14As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VIVSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (56.53%)
Div yield —
ROE (343.10%)
Biotechnology
Beta (5Y) 1.56
PE TTM —
TSR TTM (94.76%)
Mkt cap US$2.349M
ROIC (170.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.177
25.18%
119.56%
Hold 8|0|10|2|3
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
4.72%
6.54%
5.59%
9.12%
Revenue$M
0.125
0.127
0.130
0.137
0.88%
5.08%
8.03%
11.06%
Peers (US$2.349M)
Cap (US$)
PE
2.281M
—
Capital
TTM
5Y
10Y
Leveragex
0.170
(0.439)
(0.436)
EBIT/Intx
1.186
0.336
0.393
Own earn%
(23.27)
(18.70)
(8.66)
Sh yield%
39.93
32.54
31.85
Owners
Insiders/Inst%
2.77
57.36
Short interest%
3.17
SBC / revenue%
0.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–8
$1 testx
—
Incr. ROIC%
0